Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC

Fazel,Asita; Quabius,Elgar Susanne; Gonzales‑donate,Mireia; Laudien,Martin; Herzog,Arved; Kress,Konstantin; Schleicher,Thilo; Fabian,Alexander; Huber,Karen; Hoffmann,Markus

doi:10.3892/mco.2020.2120

Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC

Authors:
- Asita Fazel
- Elgar Susanne Quabius
- Mireia Gonzales‑donate
- Martin Laudien
- Arved Herzog
- Konstantin Kress
- Thilo Schleicher
- Alexander Fabian
- Karen Huber
- Markus Hoffmann
View Affiliations

Affiliations: Department of Otorhinolaryngology, Head and Neck Surgery, Christian‑Albrechts‑University, University Hospital Schleswig‑Holstein, D‑24105 Kiel, Germany, Department of Radiooncology, Christian‑Albrechts‑University, University Hospital Schleswig‑Holstein, D‑24105 Kiel, Germany
Published online on: August 20, 2020 https://doi.org/10.3892/mco.2020.2120
Article Number: 50
Copyright: © Fazel et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The impact of smoking on survival in patients with squamous cell carcinoma of the head and neck is well established, despite some conflicting data in the literature. However, data on alterations of smoking habit following cancer diagnosis is sparse. In the present study, the effect of reduction of smoking compared with cessation on the course of disease was studied. Data from 643 patients with HNSCC from the tumor documentation registry of the Department of Otorhinolaryngology, Head and Neck Surgery of the Christian‑Albrechts‑University Kiel were collected and statistically analyzed, looking at pre‑ and post‑treatment smoking habit and survival. Alteration of smoking at the first diagnosis of HNSCC led to a significantly beneficial effect on survival outcomes compared with continued smoking, without significant differences between reduction and cessation of smoking. Detailed analysis revealed that this effect was solely dependent on patients treated by surgery only. Lifelong non‑smokers exhibited a significant survival advantage compared with active and former smokers, with no difference in survival between these last two groups. The positive influence of altered smoking habit following first time diagnosis on disease‑specific survival paralleled the negative direct effect of active smoking on therapy, which is predominantly attributed to peritumoral tissue hypoxia leading to impaired efficacy of radiochemotherapy (RCT). In the present study cohort, the positive effect of smoking habit alterations were primarily observed in patients treated by surgery only instead of RCT, possibly due to fewer perioperative complications. These findings indicated that patients should be encouraged to at least minimize smoking following cancer diagnosis. Furthermore, for survival estimates and therapy planning, former smokers should be considered as active smokers.

View Figures

View References

1	Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 363:24–35. 2010.PubMed/NCBI View Article : Google Scholar
2	Hoffmann M, Quabius ES, Tribius S, Gebhardt S, Görögh T, Hedderich J, Huber K, Dunst J and Ambrosch P: Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO₂-laser surgery plus risk adapted therapy-a 10 year retrospective single centre study. Cancer Lett. 413:59–68. 2018.PubMed/NCBI View Article : Google Scholar
3	Marur S and Forastier AA: Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 91:386–936. 2016.PubMed/NCBI View Article : Google Scholar
4	Farshadpour F, Kranenborg H, Calkoen EV, Hordijk GJ, Koole R, Slootweg PJ and Terhaard CH: Survival analysis of head and neck squamous cell carcinoma: Influence of smoking and drinking. Head Neck. 33:817–823. 2011.PubMed/NCBI View Article : Google Scholar
5	Stucken CL, de Almeida JR, Sikora AG, Tong CC and Genden EM: Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery. Head Neck. 38:380–386. 2016.PubMed/NCBI View Article : Google Scholar
6	Lassig AA, Yueh B and Joseph AM: The effect of smoking on perioperative complications in head and neck oncologic surgery. Laryngoscope. 122:1800–1808. 2012.PubMed/NCBI View Article : Google Scholar
7	Chen AM, Chen LM, Vaughan A, Farwell DG, Luu Q, Purdy JA and Vijayakumar S: Head and neck cancer among lifelong never-smokers and ever-smokers: Matched-pair analysis of outcomes after radiation therapy. Am J Clin Oncol. 34:270–275. 2011.PubMed/NCBI View Article : Google Scholar
8	Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT, Lipkus IM and Duffy SA: Does quitting smoking make a difference among newly diagnosed head and neck cancer patients? Nicotine Tob Res. 18:2216–2224. 2016.PubMed/NCBI View Article : Google Scholar
9	Sharp L, McDevitt J, Carsin AE, Brown C and Comber H: Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: Findings from a large, population-based study. Cancer Epidemiol Biomarkers Prev. 23:2579–2590. 2014.PubMed/NCBI View Article : Google Scholar
10	Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P and Levine MN: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 328:159–163. 1993.PubMed/NCBI View Article : Google Scholar
11	Fountzilas G, Kosmidis P, Avramidis V, Nikolaou A, Kalogera-Fountzila A, Makrantonakis P, Bacoyiannis C, Samantas E, Skarlos D and Daniilidis J: Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A Hellenic Co-operative oncology group study. Med Pediatr Oncol. 28:401–410. 1997.PubMed/NCBI View Article : Google Scholar
12	Grønkjær M, Eliasen M, Skov-Ettrup LS, Tolstrup JS, Christiansen AH, Mikkelsen SS, Becker U and Flensborg-Madsen T: Preoperative smoking status and postoperative complications: A systematic review and meta-analysis. Ann Surg. 259:52–71. 2014.PubMed/NCBI View Article : Google Scholar
13	Wandt H, Schäfer-Eckart K and Greinacher A: Platelet transfusion in hematology, oncology and surgery. Dtsch Arztebl Int. 111:809–815. 2014.PubMed/NCBI View Article : Google Scholar
14	Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH and Ang KK: Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 30:2102–2111. 2012.PubMed/NCBI View Article : Google Scholar
15	Hong AM, Martin A, Chatfield M, Jones D, Zhang M, Armstrong B, Lee CS, Harnett G, Milross C, Clark J, et al: Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int J Cancer. 132:2748–2754. 2013.PubMed/NCBI View Article : Google Scholar
16	Beynon RA, Lang S, Schimansky S, Penfold CM, Waylen A, Thomas SJ, Pawlita M, Waterboer T, Martin RM, May M and Ness AR: Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer. Int J Cancer. 143:1114–1127. 2018.PubMed/NCBI View Article : Google Scholar
17	Peterson LA, Bellile EL, Wolf GT, Virani S, Shuman AG, Taylor JM and Rozek LS: University of Michigan Head and Neck Specialized Program of Research Excellence Program. Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population. Head Neck. 38:1810–1820. 2016.PubMed/NCBI View Article : Google Scholar
18	Dumanski JP, Rasi C, Lönn M, Davies H, Ingelsson M, Giedraitis V, Lannfelt L, Magnusson PK, Lindgren CM, Morris AP, et al: Mutagenesis Smoking is associated with mosaic loss of chromosome Y. Sience. 347:81–83. 2015.PubMed/NCBI View Article : Google Scholar
19	Kawakita D, Hosono S, Ito H, Oze I, Watanabe M, Hanai N, Haseqawa Y, Tajima H, Murakami S, Tanaka H and Matsuo K: Impact of smoking status on clinical outcome in oral cavity cancer patients. Oral Oncol. 48:186–191. 2012.PubMed/NCBI View Article : Google Scholar
20	Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M and Kato I: Characteristics and survival of head and neck cancer by HPV status: A cancer registry-based study. Int J Cancer. 131:1179–1186. 2012.PubMed/NCBI View Article : Google Scholar
21	Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, MacKenzie RG, El-Sayed S, Dunn E and Farrell S: Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow-up study. Head Neck. 24:1031–1037. 2002.PubMed/NCBI View Article : Google Scholar